PEOPLE - Changes at UroMed (US):
This article was originally published in Clinica
Executive Summary
Paul Murphy has resigned as chief financial officer of UroMed, a US developer of interventional urological products, to pursue other interests. Domenic Micale has been promoted to director of finance. Mr Micale and John Simon, president and CEO of UroMed, will jointly assume Mr Murphy's responsibilities.